PRNewsWire
08 Aug 2026, 19:35 UTC · 2h ago
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
PRNewsWire
08 Aug 2026, 19:35 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
iRhythm Technologies (IRTC) is facing a federal securities lawsuit alleging that insiders misrepresented the capabilities and market penetration of the Zio AT monitor. — Allegations of fraud and misrepresentation regarding a core product typically lead to investor distrust and potential downward pressure on the stock price.
-0.60Kuehn Law is investigating whether officers and directors of iRhythm Technologies breached their fiduciary duties to shareholders. — Law firm solicitations for shareholder derivative suits signal increasing legal risk and potential future settlements or management turnover.
-0.30Which stocks this story touches
The company is being investigated by a law firm for potential breaches of fiduciary duty by its officers and directors.
Continue reading
6 related stories
Top 2 movers · tap to explore
The company is being investigated by a law firm for potential breaches of fiduciary duty by its officers and directors.
The company is facing a shareholder litigation investigation regarding alleged misrepresentations of its Zio AT monitor.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Business Wire
1h ago
